Friday, October 3, 2025

8:45 AM - 9:10 AM

---

Session Details

By the end of this session participants will be able to: 1. Identify the types of EGFR mutation outside of the typical exon 19 deletion and exon 21 L858R mutation and how the clinical course of tumours with these atypical mutations may vary from those with the classic mutations 2. Describe targeted therapies for atypical / PACC / exon 20 insertion EGFR mutations based on the type and location of the mutation